Moderna has moved three vaccines into final stage trials and secured a $750 million funding from Blackstone Life Sciences to develop flu shots. The collaboration aims to support Moderna's innovative mRNA technology and help the company rebound from the post-COVID sales slump.
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's annual vaccines day, the announcement of multiple vaccine programs advancing to late-stage clinical trials: "I couldn't be happier because not only our respiratory vaccines are doing extremely well in term of… https://t.co/C5iWk9nEpR
Moderna reports promising findings for next-generation COVID vaccine The new version offers longer shelf-life advantages and paves the way for a flu-COVID combo vaccine. https://t.co/yxswEf75e3 Photo: Diverse Stock Photos/Flickr cc https://t.co/ksCFB246R3
. @Moderna_tx’s development of mRNA #vaccines for #influenza will be backed by up to $750m in funding from @Blackstone in a risk-sharing deal. $BX $MRNA https://t.co/x8mkJ73fmU https://t.co/3fDwCjEfVS
“Moderna on Wednesday said Blackstone's life sciences arm would offer $750 million to help fund development of its flu vaccines, bolstering the company's efforts to advance multiple vaccines in the face of a steep decline in sales of its COVID-19 shots. Blackstone Life Sciences… https://t.co/lsY9MgZ6oq
Blackstone Life Sciences, a private investment company, is making a big bet on its Cambridge neighbor Moderna, the drug firm that has made multiple versions of a vaccine to fend off COVID-19. https://t.co/8HVPkHTLW0
Moderna's 2024 vaccine progress rests heavily on the (potential) approval of an RSV shot and phase 3 CMV data. But the COVID vaccine maker used part of its annual vaccine business review to unveil data from three earlier stage prospects: https://t.co/ab4QaTCYUv
Fun conversation with Alix and Romaine on Merck's newly approved drug and Moderna's $750M funding agreement with Blackstone $MRK $MRNA https://t.co/Bq7lVq1B04
Moderna gets Blackstone backing for flu vaccine R&D https://t.co/o9yaloKxyS $MRNA by @Lilah_Alvarado
Blackstone Life Sciences is making a $750 million bet on Moderna’s influenza vaccine program as part of the investment platform’s push to “support innovative mRNA technology.” https://t.co/AY3nCPIXTd
Moderna said on Wednesday Blackstone's life sciences arm would offer $750 million in funding towards its flu vaccines, bolstering its efforts to advance multiple vaccines to stem a post-COVID slump in sales. https://t.co/t6sTzmlw8H https://t.co/t6sTzmlw8H
$750 Ms - I Fink that Blackstone moves in size….🤑 Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program https://t.co/MimQWOPk8X
Moderna secures $750 mln from Blackstone Life Sciences to develop flu shots https://t.co/qJYzXH8hdo https://t.co/aJioaMoKde
For those keeping track, Blackstone has invested 7% ($750mn) of what the US government has invested ($10bn) in mRNA technology at Moderna alone. Blackstone gets 'commercial milestone payments' and royalties. In contrast, NIH had to threaten legal action. https://t.co/SjuHBqzmAa https://t.co/fLWuS8cHXS
$MRNA (+3.7% pre) Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump - CNBC https://t.co/fzWy4Pu829
Moderna Gets $750 Million for Flu Program. Funding to Help Move Beyond Covid Vaccines. https://t.co/4ces5I6kY3
One of Moderna's three new vaccines going on trial is for the norovirus! I sure hope that one works, though I would've wanted to have it before having kids (they bring back so many stomach bugs from daycare/school). https://t.co/8y3lj3HO4l
Moderna said on Wednesday it has entered into an agreement with private equity firm Blackstone's life science investment platform for a funding of $750 million to develop its mRNA flu vaccines. https://t.co/37dV03H4FH https://t.co/37dV03H4FH
⚠️ MODERNA GETS $750 MILLION FUNDING FROM BLACKSTONE LIFE SCIENCES TO DEVELOP FLU SHOTS Full Story → https://t.co/ITSDNAsCAL https://t.co/1ZEteiKY8b
$BX Blackstone Life Sciences Announces Collaboration to Support $MRNA Influenza Program. Blackstone to invest up to $750M to support innovative mRNA technology. https://t.co/8IYdInHrMu
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump https://t.co/LhdOxhP1ql